These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 9217779)

  • 1. Bayesian interim analysis of randomised trials.
    Abrams KR; Jones DR
    Lancet; 1997 Jun; 349(9069):1911-2. PubMed ID: 9217779
    [No Abstract]   [Full Text] [Related]  

  • 2. Bayesian interim statistical analysis of randomised trials.
    Brophy JM; Joseph L
    Lancet; 1997 Apr; 349(9059):1166-8. PubMed ID: 9113025
    [No Abstract]   [Full Text] [Related]  

  • 3. Bayesian interim analysis of randomised trials.
    Fayers P
    Lancet; 1997 Jun; 349(9069):1911. PubMed ID: 9217778
    [No Abstract]   [Full Text] [Related]  

  • 4. The ethics of randomised controlled trials: a matter of statistical belief?
    Hutton JL
    Health Care Anal; 1996 May; 4(2):95-102. PubMed ID: 10162773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bayesian interim statistical analysis of randomised trials: the case against.
    Køber L; Torp-Pedersen C; Cole D; Hampton JR; Camm AJ
    Lancet; 1997 Apr; 349(9059):1168-9. PubMed ID: 9113026
    [No Abstract]   [Full Text] [Related]  

  • 6. Practical problems in interim analyses, with particular regard to estimation.
    Pocock SJ; Hughes MD
    Control Clin Trials; 1989 Dec; 10(4 Suppl):209S-221S. PubMed ID: 2605969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bayesian interim analysis of randomised trials.
    Hall GH
    Lancet; 1997 Jun; 349(9069):1910-1. PubMed ID: 9217777
    [No Abstract]   [Full Text] [Related]  

  • 8. On clinical trials in psychiatry.
    Greenhouse JB
    Biol Psychiatry; 2000 Sep; 48(6):433-5. PubMed ID: 11018215
    [No Abstract]   [Full Text] [Related]  

  • 9. Ethics of randomised controlled trials--not yet time to give up on equipoise.
    Ashcroft RE
    Arthritis Res Ther; 2004; 6(6):237-9. PubMed ID: 15535836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Annals of Emergency Medicine Journal Club. Outcome measures, interim analyses, and Bayesian approaches to randomized trials: answers to the September 2009 Journal Club questions.
    Brown AM; Schriger DL; Barrett TW
    Ann Emerg Med; 2010 Feb; 55(2):216-224.e1. PubMed ID: 20116032
    [No Abstract]   [Full Text] [Related]  

  • 11. Continuous Bayesian adaptive randomization based on event times with covariates by Cheung et al., Statistics in Medicine 2006; 25:55-70.
    Chappell R; Karrison T
    Stat Med; 2007 Jul; 26(15):3050-2; author reply 3052-4. PubMed ID: 17163577
    [No Abstract]   [Full Text] [Related]  

  • 12. Bayesian statistical inference enhances the interpretation of contemporary randomized controlled trials.
    Wijeysundera DN; Austin PC; Hux JE; Beattie WS; Laupacis A
    J Clin Epidemiol; 2009 Jan; 62(1):13-21.e5. PubMed ID: 18947971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Bayesian group sequential approach to safety signal detection.
    Chen W; Zhao N; Qin G; Chen J
    J Biopharm Stat; 2013; 23(1):213-30. PubMed ID: 23331232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Applying Bayesian ideas in drug development and clinical trials.
    Spiegelhalter DJ; Freedman LS; Parmar MK
    Stat Med; 1993 Aug; 12(15-16):1501-11; discussion 1513-7. PubMed ID: 8248659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adaptive randomization versus interim monitoring.
    Freidlin B; Korn EL
    J Clin Oncol; 2013 Mar; 31(7):969-70. PubMed ID: 23341515
    [No Abstract]   [Full Text] [Related]  

  • 16. Re: "use of a Bayesian approach to decide when to stop a therapeutic trial: the case of a chemoprophylaxis trial in human immunodeficiency virus infection".
    van Noord PA; van der Tweel I
    Am J Epidemiol; 2005 Nov; 162(10):1033-5. PubMed ID: 16221807
    [No Abstract]   [Full Text] [Related]  

  • 17. A Bayesian adaptive design for multi-dose, randomized, placebo-controlled phase I/II trials.
    Xie F; Ji Y; Tremmel L
    Contemp Clin Trials; 2012 Jul; 33(4):739-48. PubMed ID: 22426247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring of large randomised clinical trials: a new approach with Bayesian methods.
    Parmar MK; Griffiths GO; Spiegelhalter DJ; Souhami RL; Altman DG; van der Scheuren E;
    Lancet; 2001 Aug; 358(9279):375-81. PubMed ID: 11502318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Each generation improves on the last (in cardiology): Bayesian thinking, the randomized clinical trial, and directed evolution.
    Morrison DA
    Catheter Cardiovasc Interv; 2011 Jun; 77(7):1018-9. PubMed ID: 21598353
    [No Abstract]   [Full Text] [Related]  

  • 20. Ethical issues in the design and conduct of randomised controlled trials.
    Edwards SJ; Lilford RJ; Braunholtz DA; Jackson JC; Hewison J; Thornton J
    Health Technol Assess; 1998 Dec; 2(15):i-vi, 1-132. PubMed ID: 10194615
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.